<?xml version="1.0" encoding="UTF-8"?>
<ref id="B150-pharmaceuticals-12-00147">
 <label>150.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yu</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Rao</surname>
    <given-names>Z.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>PDlim2 selectively interacts with the PDZ binding motif of highly pathogenic avian H5N1 influenza A virus NS1</article-title>
  <source>PLoS ONE</source>
  <year>2011</year>
  <volume>6</volume>
  <elocation-id>e19511</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0019511</pub-id>
  <pub-id pub-id-type="pmid">21625420</pub-id>
 </element-citation>
</ref>
